Hong Kong Stocks Open 1.08% Higher, Pharma Stocks Lead Gains, BeiGene Surges Over 4%
nashnova research
The Hang Seng Index opened up 1.08% at 24,321 on October 16, with all 12 sector indices in the green; healthcare led gains at 2.47%, supported by an overnight Wall Street rally and a pullback in U.S. Treasury yields.
How much did the four major indices gain at the open?
The Hang Seng Index opened at 24,321.45, up 1.08%; the Hang Seng Tech Index rose 1.59% to 4,125.44.
The H-share Index gained 1.19%; the Red Chip Index added 0.61% — all four benchmarks opened higher.
This means → the opening bid was broadly optimistic, not chasing a single sector but lifting the market across the board.
Which sectors gained the most — and which lagged?
Hang Seng Healthcare rose 2.47%, topping all 12 sectors; Consumer Discretionary gained 1.64% and IT added 1.46%.
Telecoms (up 0.18%) and Utilities (up 0.20%) brought up the rear — up, but barely.
In plain terms = money flowed first into higher-growth pharma and tech; defensive sectors just tagged along.
Which stocks stood out?
Among HSI constituents, BeiGene surged 4.27%, Innovent Bio gained 3.99%, and New Oriental rose 3.17% — the top three were all pharma or consumer names.
In the Tech Index, MINIMAX-W rose 4.01%, Tiantong Zhixin gained 3.76%, and NIO added 3.63% — AI and EV concepts led.
Decliners were rare: CATL fell 2.23% notably; Xiaomi dipped just 0.22%, the only Tech Index constituent in the red.
Why was pharma so strong?
Connect Biopharma reported that its product Kangeyueda generated roughly RMB 660 million in revenue for the first three quarters, up about 227% year-on-year — a direct earnings catalyst.
Separately, China's drug regulator approved a new indication for supkicimab — a biologic for allergic skin conditions — to treat adolescents, opening a fresh market segment.
This means → today's pharma rally has fundamental backing, not just sentiment-driven momentum.
What support came from overseas markets?
U.S. stocks closed higher overnight: the Dow rose 1.08%, the S&P 500 gained 0.33%, and the Nasdaq edged up 0.08%.
The U.S. 10-year Treasury yield pulled back to around 5.09% — this reflects a slight cooling in rate-hike expectations, easing valuation pressure on Hong Kong equities.
Whether pharma can sustain its rally still depends on follow-through from capital flows — a strong open does not guarantee a strong close.
市场有风险，内容仅供研究参考，不构成投资建议。